News

Stocks were under pressure Thursday when bond yields rose after President Trump's tax and spending bill passed the House Thursday morning, which would avert a year-end tax increase at the expense of ...
Leerink Partnrs also issued estimates for Elevance Health’s Q4 2025 earnings at $4.03 EPS, FY2025 earnings at $34.37 EPS, Q3 2026 earnings at $9.87 EPS, Q4 2026 earnings at $5.03 EPS ...
Elevance Health is ramping up care coordination with new members in a move the company says helps it predict and prepare for medical cost trends that have dogged the health insurance sector.
Despite rising costs in its health plans, Elevance Health reported more than $2 billion in first quarter net income thanks to growth across its health plans and Carelon health services business.
Elevance Health has become a key contender in the booming telehealth ... They expect state payments to rise soon, restoring profitability to previous levels. The company’s Q4 2024 earnings revealed ...
Elevance Health saw a bit of a portfolio weight loss as Level Four Advisory Services LLC trimmed its holdings by 18.2% in Q4. Other institutional investors, however, were busy bulking up, showing ...
River Road Large Cap Value Select Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “Another bottom contributor during the quarter was Elevance ...
Artisan Select Equity Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “Elevance Health, Inc. (NYSE:ELV) took a couple of blows this quarter.
Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...
Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...
Elevance Health’s share price has started 2025 off nicely, up over 9% on the year. It provided a total return of -21% in 2024. Shares gained moderately after the company reported its Q4 earnings ...